Skip to content

ALPHAMEDIS

Active Public limited companyfounded 1995active for 30 yearsAvenue de l'Energie 8, 4432 AnsKBO/BCE: BE 0456.605.328 subsidiary of

Lifetime

22 annual accounts with figures on one time axis, 30 filings since 1996
peak of €2.5m in 2020
€1.3mprevious year 15 months
lowest -€482,638 in 2025
-€424,537previous year 15 months
peak of €2.4m in 2022
€951,661▼ 30.8%
€1.2m▲ 46.7%
peak of 21.5 FTE in 2026
21.5 FTE▲ 8.0%
Board5 names since 2016
4 directors and 3 others
Owners2 names in the annual accounts
consolidates
Documentsfilings and deeds
17-09-202644 days before the deadline
2026abbreviated format
Loss of €424,537Staff from 19.9 FTE to 21.5 FTEEquity from €1.4m to €951,661Debts from €808,916 to €1.2m

Key points

from the 2026 annual accounts

Equity

€951,661 from €2.4m in 2022

Equity fell by 61% in 4 years.

Losses

-€1.1m in three years
-166,1932023-482,6382025-424,5372026

Every financial year from 2023 to 2026 closed with a loss. 2025 was the heaviest.

Turnover

≈ €5.5m estimated

The accounts state no turnover.

Staff

24 employees on 31-03-2026
312021482022332023432025412026

In 2026, 4 employees joined and 1 left.

Filings

30 annual accounts since 1996
deadline200020102020

The last five annual accounts were filed 43 to 110 days before the end of the period.

Position in the sector

-€424,537

Lower net result than 95% of companies in wholesale trade. The sector median is €47,424, over 715 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 929 companies had the same profile as ALPHAMEDIS has now. Each dot stands for 3 companies, two years later.

90.0%
were still trading
8.9%
stopped another way
1.1%
went bankrupt
  • Small
  • 20 years or older
  • solvency 30% or more
  • a loss of 10% of the balance sheet or more
Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 929 companies, not a prediction for ALPHAMEDIS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Director
Director, since 02-02-2024
Director, since 02-02-2024
Auditor
  • consolidatesannual accounts 31-03-2026
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0456605328
Amendment of the articles General meeting of 29-07-2024 · Gazette deed
(director) and (director) appointed General meeting of 02-02-2024 · Gazette deed
(director) and (director) reappointed General meeting of 28-05-2021 · Gazette deed
All 50 events

Comparable companies

same main activity, similar in size and age
Company
ALPHAMEDIS Ans €2.2m €1.3m 44.1% 21.5
CHIRURGICAL MAINTENANCE Flémalle €2.7m €1.8m 29.2% 14.6
ASTEL MEDICA Neupré €2.6m €2.1m 53.2% 14.6
AB-TECHNICS Malle €2.9m €1.3m 29.1% 17.1
LPG BENELUX Drogenbos €3.5m €1.2m -46.7% 17.2
Europhar Genappe €3.5m €1.6m 6.6% 16.1
LABORATOIRES EXPANSCIENCE BELGIUM Asse €3.2m €2.3m 37.3% 20.4

These companies have the same main activity as ALPHAMEDIS: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €2.6m and €3.5m, founded between 1990 and 2000.

Official details

Source: KBO
Status
Active since 27-11-1995Normal situation
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460and 1 other
Joint committee
201Independent retail · annual accounts 31-03-2026
Establishment units
2.149.934.4274432 Ans, registered on 15-11-2005
2.233.028.1897522 Tournai, since 01-06-2007and 1 other
Financial year end
31 March
Peppol
Reachable since 25-11-2025
Company details

Annual accounts to 31-03-2026

€2.2m▼ 2.1%
Employeeson 31-03-2026
24▲ 14.3%
Filing
Filed on 17-09-2026, 44 days before the end of the filing period
Financials

Insights on ALPHAMEDIS

ALPHAMEDIS files the abbreviated format. That format states no turnover. The gross margin rose from €1.1m in 2005 to €1.3m in 2026.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about ALPHAMEDIS

What is the company number of ALPHAMEDIS?
The company number of ALPHAMEDIS is 0456.605.328. The VAT number is the same number with BE in front: BE 0456.605.328.
Where is ALPHAMEDIS based?
The registered office is at Avenue de l'Energie 8, 4432 Ans.Company details
What does ALPHAMEDIS do?
According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
What is the legal form of ALPHAMEDIS?
ALPHAMEDIS is a public limited company (NV).
When was ALPHAMEDIS founded?
ALPHAMEDIS was founded on 27-11-1995.
Is ALPHAMEDIS still active?
Yes, ALPHAMEDIS is an active enterprise in the KBO register.
How many employees does ALPHAMEDIS have?
ALPHAMEDIS had an average of 21.5 full-time equivalents in financial year 2026, according to the filed annual accounts.Financials
Which joint committee does ALPHAMEDIS fall under?
In its 31-03-2026 annual accounts, ALPHAMEDIS states joint committee 201 (Independent retail).
What is the turnover of ALPHAMEDIS?
The turnover in financial year 2026 is about €5.5m. This figure is estimated from the gross margin of €1.3m and 97 comparable companies (NACE 46). It probably lies between €3.4m and €9.3m.
Is ALPHAMEDIS profitable?
In financial year 2026, ALPHAMEDIS made a loss of €424,537.
Where can I find the annual accounts of ALPHAMEDIS?
ALPHAMEDIS filed 30 annual accounts with the National Bank of Belgium, the latest for financial year 2026.
When are the next annual accounts of ALPHAMEDIS due?
ALPHAMEDIS must file the annual accounts for financial year 2027 by 31-10-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.